Healthcare BPO, already a USD 170 billion market in 2016, continues to grow above 10% annually. Some of the most high-tech and promising emergent specialties are in the areas of nano- and biotechnology. Global pharmaceutical and medical device manufacturing companies increasingly rely on specialized clinical and preclinical research, and customized bio-manufacturing.
As a result, the biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025 (Grand View Research). Breakthrough technologies like gene editing, immunotherapy, nanotechnology, and big data are all expected to have a big impact on the direction of this sector in the coming years. In this groundbreaking growth market, how is the LAC region developing and promoting its capabilities to deliver innovative, specialized, and secure health services?
- Massimo Manzi, Executive Director of the Council for the International Promotion of Costa Rica
Medicine - PROMED
- Gabriela Couto, CEO of Marketplaza and President of the CR Biomed Cluster
- Ricardo Salazar, Head, Government and Public Affairs & Advocacy for Latin America, Sanofi
- KP Bannanje, Senior Director - Consulting Services, Neusoft America